Anil K Attili, MD | |
1500 E Medical Center Drive, B1 Floor University Hospital Recp C, Ann Arbor, MI 48109-5030 | |
(734) 936-4566 | |
Not Available |
Full Name | Anil K Attili |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 29 Years |
Location | 1500 E Medical Center Drive, Ann Arbor, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386724250 | NPI | - | NPPES |
4531817 | Medicaid | MI | |
7100078020 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 4301081838 (Michigan) | Primary |
2085R0202X | Radiology - Diagnostic Radiology | 42892 (Kentucky) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Michigan Health System | Ann arbor, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
The protein MALT1 is an important switch in immune cells and affects their activity. Researchers at Helmholtz Zentrum München report in 'Nature Communications' that this activation is not always equally strong. Through alternative splicing, two variants of the protein may arise which have a stronger or weaker effect on the immune system. Understanding this process is important for the pharmacological use of MALT1.
With most countries at a standstill, the circulating novel coronavirus has changed the way people live. Though some countries are starting to ease lockdown measures, with schools reopening, health experts worry that this may aggravate the situation. Two new studies provide evidence that children spread the coronavirus and transmit it, making them potential carriers of the infection.
Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate calcium 451 mcg tablets). In women who choose an OC for birth control, SAFYRAL raises folate levels for the purpose of reducing the risk of rare neural tube defects (NTDs) in a pregnancy conceived while taking SAFYRAL or shortly after discontinuing it.
When individuals with breast or prostate cancer followed a moderate, home-based exercise program using resistance bands and walking, the patients had less fatigue during radiation treatments, greater strength and could walk farther and faster in only four weeks, researchers discovered in a pilot study.
› Verified 4 days ago
Entity Name | Regents Of The University Of Michigan |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205868353 PECOS PAC ID: 3779496856 Enrollment ID: O20031106000325 |
News Archive
The protein MALT1 is an important switch in immune cells and affects their activity. Researchers at Helmholtz Zentrum München report in 'Nature Communications' that this activation is not always equally strong. Through alternative splicing, two variants of the protein may arise which have a stronger or weaker effect on the immune system. Understanding this process is important for the pharmacological use of MALT1.
With most countries at a standstill, the circulating novel coronavirus has changed the way people live. Though some countries are starting to ease lockdown measures, with schools reopening, health experts worry that this may aggravate the situation. Two new studies provide evidence that children spread the coronavirus and transmit it, making them potential carriers of the infection.
Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate calcium 451 mcg tablets). In women who choose an OC for birth control, SAFYRAL raises folate levels for the purpose of reducing the risk of rare neural tube defects (NTDs) in a pregnancy conceived while taking SAFYRAL or shortly after discontinuing it.
When individuals with breast or prostate cancer followed a moderate, home-based exercise program using resistance bands and walking, the patients had less fatigue during radiation treatments, greater strength and could walk farther and faster in only four weeks, researchers discovered in a pilot study.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Anil K Attili, MD 3621 S State St, 700 Kms Place, Ann Arbor, MI 48108 Ph: (734) 936-2047 | Anil K Attili, MD 1500 E Medical Center Drive, B1 Floor University Hospital Recp C, Ann Arbor, MI 48109-5030 Ph: (734) 936-4566 |
News Archive
The protein MALT1 is an important switch in immune cells and affects their activity. Researchers at Helmholtz Zentrum München report in 'Nature Communications' that this activation is not always equally strong. Through alternative splicing, two variants of the protein may arise which have a stronger or weaker effect on the immune system. Understanding this process is important for the pharmacological use of MALT1.
With most countries at a standstill, the circulating novel coronavirus has changed the way people live. Though some countries are starting to ease lockdown measures, with schools reopening, health experts worry that this may aggravate the situation. Two new studies provide evidence that children spread the coronavirus and transmit it, making them potential carriers of the infection.
Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate calcium 451 mcg tablets). In women who choose an OC for birth control, SAFYRAL raises folate levels for the purpose of reducing the risk of rare neural tube defects (NTDs) in a pregnancy conceived while taking SAFYRAL or shortly after discontinuing it.
When individuals with breast or prostate cancer followed a moderate, home-based exercise program using resistance bands and walking, the patients had less fatigue during radiation treatments, greater strength and could walk farther and faster in only four weeks, researchers discovered in a pilot study.
› Verified 4 days ago
Chiemezie Chianotu Amadi, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Patrick Charles Albus, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. Michael James Todd, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Perry G Pernicano, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, B1 Floor University Hospital Recp C, Ann Arbor, MI 48109 Phone: 734-936-4566 | |
Ellen G Hoeffner, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, B1 Floor University Hospital Recp C, Ann Arbor, MI 48109 Phone: 734-936-4566 | |
Dr. Christopher Robert Nall, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. Stephen Michael Ascherl, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2375 Newport Rd, Ann Arbor, MI 48103 Phone: 734-327-0649 Fax: 734-327-0649 |